NEW YORK – Guardant Health announced Tuesday that its Guardant Reveal liquid biopsy test has received coverage from Medicare administrative contractor Palmetto GBA to monitor colorectal cancer ...
Shares of Guardant Health (NASDAQ:GH) have increased by 5.0% in premarket trading Tuesday following the company's ...
Guardant Health has secured Medicare coverage from Palmetto for its blood test to monitor for disease recurrence in patients with colorectal cancer.
Shares of Guardant Health (NASDAQ:GH) jumped 12% in early trading Tuesday on news that Medicare coverage for its Guardant Reveal blood test has been expanded to include monitoring for disease ...
President Trump's inaugural address to the nation on Monday contained few references to healthcare, but the health topics he ...
But when her lung collapsed again years later, she had Medicaid coverage. Wynn was admitted to the hospital, received ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that the first set of abstracts have been released from several studies that will be shared at the ...
Cancer diagnostics company Pacific Edge says it will seek a preliminary injunction in the US if it fails to achieve a timely ...
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.